| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.05 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |